Skip to main navigation Skip to search Skip to main content

Lilly LRAP - Targeting incretin signalling pathways in osteoarthritis synovial fibroblasts: A novel therapeutic approach for joint pain

Project Details

Short titleLilly LRAP - Targeting incretin signalling pathways in osteoarthritis synovial fibroblasts: A novel therapeutic approach for joint pain
StatusActive
Effective start/end date27/05/25 → 26/05/27

Funding

  • Eli Lilly & Company